This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Masataka Chihara: Innovator in Antibody-Drug Conjugates
Introduction
Masataka Chihara is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions.
Latest Patents
Masataka Chihara holds a patent for an "ANTI-EGFR ANTIBODY-DRUG CONJUGATE WITH A CYCLIC DINUCLEOTIDE DERIVATIVE." This invention represents a notable advancement in targeted cancer therapies, showcasing his expertise in the intersection of immunology and drug development. He has 1 patent to his name.
Career Highlights
Chihara is currently associated with Daiichi Sankyo Company, Limited, a leading global pharmaceutical company. His work at Daiichi Sankyo focuses on developing innovative treatments that address critical medical needs.
Collaborations
Masataka Chihara has collaborated with notable colleagues, including Masayuki Ishizaki and Osamu Suzuki. These partnerships have contributed to the advancement of research and development in their respective fields.
Conclusion
Masataka Chihara's contributions to biotechnology and his innovative patent work exemplify the impact of dedicated inventors in the medical field. His ongoing efforts continue to pave the way for future advancements in cancer treatment.